fda warning peptides bpc-157 not approved human use FDA's Review Of Signals A Growing Public Health Challenge bpc 157 fda warning not

(2023, March 6)

In laboratory research, the peptide is investigated for its role in signaling pathways associated with nitric oxide regulation, angiogenic signaling cascades, and cellular stress responses

Two separate human clinical trials have investigated this compound: Ulcerative Colitis Trial Clinical investigation of this compound in patients with ulcerative colitis examined the compounds GI-protective properties properties that are consistent with its gastric origin and documented activity on intestinal permeability barriers in animal models

The production dosage forms involved powder, extraction of Chinese traditional medicine, large and small volume injections, disinfectants, feed additives and so forth